• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型磺胺甲恶唑脲类和草酰胺作为潜在的抗分枝杆菌药物

Novel Sulfamethoxazole Ureas and Oxalamide as Potential Antimycobacterial Agents.

作者信息

Krátký Martin, Stolaříková Jiřina, Vinšová Jarmila

机构信息

Department of Organic and Bioorganic Chemistry, Faculty of Pharmacy in Hradec Králové, Charles University, Heyrovského 1203, 50005 Hradec Králové, Czech Republic.

Laboratory for Mycobacterial Diagnostics and Tuberculosis, Regional Institute of Public Health in Ostrava, Partyzánské námĕstí 7, 70200 Ostrava, Czech Republic.

出版信息

Molecules. 2017 Mar 28;22(4):535. doi: 10.3390/molecules22040535.

DOI:10.3390/molecules22040535
PMID:28350331
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6154292/
Abstract

Infections caused by () and nontuberculous mycobacteria (NTM) are considered to be a global health problem; current therapeutic options are limited. Sulfonamides have exhibited a wide range of biological activities including those against mycobacteria. Based on the activity of 4-(3-heptylureido)--(5-methylisoxazol-3-yl)benzenesulfonamide against NTM, we designed a series of homologous sulfamethoxazole-based -alkyl ureas (C₁-C), as well as several related ureas and an oxalamide. Fifteen ureas and one oxalamide were synthesized by five synthetic procedures and characterized. They were screened for their activity against and three NTM strains (, ). All of them share antimycobacterial properties with minimum inhibitory concentration (MIC) values starting from 2 µM. The highest activity showed 4,4'-[carbonylbis(azanediyl)]bis[-(5-methylisoxazol-3-yl)benzenesulfonamide] with MIC of 2-62.5 µM (i.e., 1.07-33.28 µg/mL). Among -alkyl ureas, methyl group is optimal for the inhibition of both and NTM. Generally, longer alkyls led to increased MIC values, heptyl being an exception for NTM. Some of the novel derivatives are superior to parent sulfamethoxazole. Several urea and oxalamide derivatives are promising antimycobacterial agents with low micromolar MIC values.

摘要

由()和非结核分枝杆菌(NTM)引起的感染被认为是一个全球健康问题;目前的治疗选择有限。磺胺类药物已表现出广泛的生物活性,包括对分枝杆菌的活性。基于4-(3-庚基脲基)-(5-甲基异恶唑-3-基)苯磺酰胺对NTM的活性,我们设计了一系列基于磺胺甲恶唑的同系物 - 烷基脲(C₁ - C),以及几种相关的脲和一种草酰胺。通过五种合成方法合成并表征了十五种脲和一种草酰胺。筛选了它们对()和三种NTM菌株(,)的活性。它们都具有抗分枝杆菌特性,最低抑菌浓度(MIC)值从2μM开始。活性最高的是4,4'-[羰基双(氮杂二亚基)]双[ - (5-甲基异恶唑-3-基)苯磺酰胺],MIC为2 - 62.5μM(即1.07 - 33.28μg/mL)。在 - 烷基脲中,甲基对于抑制()和NTM都是最佳的。一般来说,较长的烷基会导致MIC值增加,庚基对NTM来说是个例外。一些新型衍生物优于母体磺胺甲恶唑。几种脲和草酰胺衍生物是有前景的抗分枝杆菌药物,MIC值在低微摩尔范围内。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce5b/6154292/e26ccc420a8d/molecules-22-00535-sch005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce5b/6154292/c3ba3e2bb27e/molecules-22-00535-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce5b/6154292/0d70c0c5864f/molecules-22-00535-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce5b/6154292/1e5872077257/molecules-22-00535-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce5b/6154292/e790d2fc7ad3/molecules-22-00535-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce5b/6154292/e26ccc420a8d/molecules-22-00535-sch005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce5b/6154292/c3ba3e2bb27e/molecules-22-00535-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce5b/6154292/0d70c0c5864f/molecules-22-00535-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce5b/6154292/1e5872077257/molecules-22-00535-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce5b/6154292/e790d2fc7ad3/molecules-22-00535-sch004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce5b/6154292/e26ccc420a8d/molecules-22-00535-sch005.jpg

相似文献

1
Novel Sulfamethoxazole Ureas and Oxalamide as Potential Antimycobacterial Agents.新型磺胺甲恶唑脲类和草酰胺作为潜在的抗分枝杆菌药物
Molecules. 2017 Mar 28;22(4):535. doi: 10.3390/molecules22040535.
2
Primaquine hybrids as promising antimycobacterial and antimalarial agents.原硷类杂合物作为有前途的抗分枝杆菌和抗疟药物。
Eur J Med Chem. 2018 Jan 1;143:769-779. doi: 10.1016/j.ejmech.2017.11.083. Epub 2017 Dec 2.
3
Efficient synthesis of new (R)-2-amino-1-butanol derived ureas, thioureas and acylthioureas and in vitro evaluation of their antimycobacterial activity.高效合成新型(R)-2-氨基-1-丁醇衍生的脲、硫脲和硫代酰胺,并评估其体外抗分枝杆菌活性。
Eur J Med Chem. 2013 May;63:468-73. doi: 10.1016/j.ejmech.2013.02.034. Epub 2013 Mar 5.
4
New benzimidazole derivatives as antimycobacterial agents.新型苯并咪唑衍生物作为抗分枝杆菌剂
Farmaco. 2002 Apr;57(4):259-65. doi: 10.1016/s0014-827x(02)01218-1.
5
Second generation of primaquine ureas and bis-ureas as potential antimycobacterial agents.第二代伯氨喹脒脲和双脒脲类化合物作为潜在的抗分枝杆菌药物。
Mol Divers. 2019 Aug;23(3):657-667. doi: 10.1007/s11030-018-9899-z. Epub 2018 Dec 6.
6
Design, Synthesis and Evaluation of -pyrazinylbenzamides as Potential Antimycobacterial Agents.设计、合成及评估 - 吡嗪基苯甲酰胺类化合物作为潜在的抗分枝杆菌药物。
Molecules. 2018 Sep 18;23(9):2390. doi: 10.3390/molecules23092390.
7
New lipophilic isoniazid derivatives and their 1,3,4-oxadiazole analogues: Synthesis, antimycobacterial activity and investigation of their mechanism of action.新型亲脂性异烟肼衍生物及其 1,3,4-噁二唑类似物的合成、抗分枝杆菌活性及作用机制研究。
Eur J Med Chem. 2018 May 10;151:824-835. doi: 10.1016/j.ejmech.2018.04.017. Epub 2018 Apr 10.
8
Substituted xanthones as antimycobacterial agents, Part 2: Antimycobacterial activity.作为抗分枝杆菌剂的取代氧杂蒽酮,第2部分:抗分枝杆菌活性。
Arch Pharm (Weinheim). 1998 May;331(5):193-7. doi: 10.1002/(sici)1521-4184(199805)331:5<193::aid-ardp193>3.0.co;2-s.
9
Antimycobacterial activities of 5-alkyl (or halo)-3'-substituted pyrimidine nucleoside analogs.5-烷基(或卤代)-3'-取代嘧啶核苷类似物的抗分枝杆菌活性。
Bioorg Med Chem Lett. 2012 Jan 15;22(2):1091-4. doi: 10.1016/j.bmcl.2011.11.114. Epub 2011 Dec 4.
10
Synthesis, characterization and antimycobacterial activity of Ag(I)-aspartame, Ag(I)-saccharin and Ag(I)-cyclamate complexes.Ag(I)-阿斯巴甜、Ag(I)-糖精和Ag(I)-甜蜜素配合物的合成、表征及抗分枝杆菌活性
Arch Pharm (Weinheim). 2007 Oct;340(10):538-42. doi: 10.1002/ardp.200700040.

引用本文的文献

1
Special Issue: Sulfonamides.特刊:磺胺类药物。
Molecules. 2017 Sep 29;22(10):1642. doi: 10.3390/molecules22101642.

本文引用的文献

1
Identification of KasA as the cellular target of an anti-tubercular scaffold.鉴定 KasA 为抗结核支架的细胞靶标。
Nat Commun. 2016 Sep 1;7:12581. doi: 10.1038/ncomms12581.
2
Inhibitors of the Cysteine Synthase CysM with Antibacterial Potency against Dormant Mycobacterium tuberculosis.具有抗休眠结核分枝杆菌抗菌活性的半胱氨酸合酶CysM抑制剂
J Med Chem. 2016 Jul 28;59(14):6848-59. doi: 10.1021/acs.jmedchem.6b00674. Epub 2016 Jul 13.
3
Design, synthesis and biological evaluation of N-(5-methyl-isoxazol-3-yl/1,3,4-thiadiazol-2-yl)-4-(3-substitutedphenylureido) benzenesulfonamides as human carbonic anhydrase isoenzymes I, II, VII and XII inhibitors.
N-(5-甲基异恶唑-3-基/1,3,4-噻二唑-2-基)-4-(3-取代苯基脲基)苯磺酰胺类化合物的设计、合成及对人碳酸酐酶同工酶 I、II、VII 和 XII 的抑制作用的生物学评价。
J Enzyme Inhib Med Chem. 2016;31(sup2):174-179. doi: 10.1080/14756366.2016.1197221. Epub 2016 Jun 17.
4
The "Cyclopropyl Fragment" is a Versatile Player that Frequently Appears in Preclinical/Clinical Drug Molecules.“环丙基片段”是一种经常出现在临床前/临床药物分子中的多功能成分。
J Med Chem. 2016 Oct 13;59(19):8712-8756. doi: 10.1021/acs.jmedchem.6b00472. Epub 2016 Jun 30.
5
SYNTHESIS, REACTIONS, AND BIOLOGICAL ACTIVITY OF SOME TRIAZINE DERIVATIVES CONTAINING SULFA DRUG MOIETIES.某些含磺胺类药物基团的三嗪衍生物的合成、反应及生物活性
Bioorg Khim. 2015 Jul-Aug;41(4):491-504. doi: 10.7868/s013234231504003x.
6
Synthesis of 3,3,3-trifluoroethyl isocyanate, carbamate and ureas. Anticancer activity evaluation of -(3,3,3-trifluoroethyl)-'-substituted ureas.3,3,3-三氟乙基异氰酸酯、氨基甲酸酯和脲的合成。-(3,3,3-三氟乙基)-' -取代脲的抗癌活性评估。
J Fluor Chem. 2015 Aug;176:82-88. doi: 10.1016/j.jfluchem.2015.06.005.
7
Design, synthesis and evaluation of novel polypharmacological antichlamydial agents.新型多靶点抗衣原体药物的设计、合成与评价
Eur J Med Chem. 2015 Aug 28;101:595-603. doi: 10.1016/j.ejmech.2015.07.019. Epub 2015 Jul 13.
8
Design and synthesis of novel quinoline-aminopiperidine hybrid analogues as Mycobacterium tuberculosis DNA gyraseB inhibitors.新型喹啉-氨基哌啶杂合类似物作为结核分枝杆菌DNA回旋酶B抑制剂的设计与合成
Bioorg Med Chem. 2015 May 1;23(9):2062-78. doi: 10.1016/j.bmc.2015.03.004. Epub 2015 Mar 9.
9
Design and synthesis of triazolopyrimidine acylsulfonamides as novel anti-mycobacterial leads acting through inhibition of acetohydroxyacid synthase.三氮唑嘧啶甲酰磺胺类化合物的设计与合成:一种新型抗分枝杆菌先导化合物,通过抑制乙酰羟酸合酶发挥作用。
Bioorg Med Chem Lett. 2014 May 1;24(9):2222-5. doi: 10.1016/j.bmcl.2014.02.054. Epub 2014 Feb 28.
10
N-substituted 2-isonicotinoylhydrazinecarboxamides--new antimycobacterial active molecules.N-取代的2-异烟酰肼甲酰胺——新型抗分枝杆菌活性分子。
Molecules. 2014 Mar 28;19(4):3851-68. doi: 10.3390/molecules19043851.